semaglutide 6 week results Peptide Therapy for Weight Loss at Footsteps to Wellness in Clermont, Florida The Pros and Cons of

Updated Phase 3 data from December 2025 (TRIUMPH-4 trial) pushed those numbers even higher, with the 12mg dose delivering 28.7% weight loss at 68 weeks, which works out to approximately 71 lb lost on average

Nonetheless, in both those studies, the number of participants was quite low

Convenient and effective, it offers the benefits of injectable GLP-1 therapy in a tablet form

Use at the same time each day to maintain consistent effects

The GLP-1 Bridge Program covers Wegovy, Zepbound, and Foundayo but only when prescribed for weight loss, and only under specific formulations

While semaglutide GLP-1 is an effective medication for weight management and type 2 diabetes, it is not suitable for everyone